By Brittany Trang
Publication Date: 2026-02-10 09:30:00
Three years ago, Zachary Lipton told STAT he was leaving Amazon to join the fledgling artificial intelligence scribe startup Abridge because he could see the proverbial train leaving the station. “If I don’t jump in right now, I’ll regret it,” he said at the time.
Lipton was correct. Abridge has since become one of the biggest companies using artificial intelligence to create clinical documentation from patient-doctor visits. As of its last fundraise — it raised $550 million in 2025 — the health tech unicorn is valued at more than $5 billion.
But Abridge is contending with heavyweights on every side. Just last week, electronic health system Epic, the system of record for the bulk of Abridge’s academic health system customers, announced the launch of its own AI scribe.
